Body-on-a-chip simulation with gastrointestinal tract and liver tissues suggests that ingested nanoparticles have the potential to cause liver injury
Open accessThe DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
The use of nanoparticles in medical applications is highly anticipated, and at the same time little is known about how these nanoparticles affect human tissues. Here we have simulated the oral uptake of 50 nm carboxylated polystyrene nanoparticles with a microscale body-on-a-chip system (also referred to as multi-tissue microphysiological system or micro Cell Culture Analog). Using the 'GI tract-liver-other tissues' system allowed us to observe compounding effects and detect liver tissue injury at lower nanoparticle concentrations than was expected from experiments with single tissues. To construct this system, we combined in vitro models of the human intestinal epithelium, represented by a co-culture of enterocytes (Caco-2) and mucin-producing cells (TH29-MTX), and the liver, represented by HepG2/C3A cells, within one microfluidic device. The device also contained chambers that together represented the liquid portions of all other organs of the human body. Measuring the transport of 50 nm carboxylated polystyrene nanoparticles across the Caco-2/HT29-MTX co-culture, we found that this multi-cell layer presents an effective barrier to 90.5 ± 2.9% of the nanoparticles. Further, our simulation suggests that a larger fraction of the 9.5 ± 2.9% nanoparticles that travelled across the Caco-2/HT29-MTX cell layer were not large nanoparticle aggregates, but primarily single nanoparticles and small aggregates. After crossing the GI tract epithelium, nanoparticles that were administered in high doses estimated in terms of possible daily human consumption (240 and 480 × 10(11) nanoparticles mL(-1)) induced the release of aspartate aminotransferase (AST), an intracellular enzyme of the liver that indicates liver cell injury. Our results indicate that body-on-a-chip devices are highly relevant in vitro models for evaluating nanoparticle interactions with human tissues.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“At the same time, they overcame the inaccessibility of cystic organoids and clearance of cell debris by creating a perfusable culture of mini-intestines where cells are arranged to form tube-shaped epithelia and similar spatial arrangement as the in vivo tissue100.”
From Organoids (2022) · cites this paper as [100]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“creation of Intestine Chips can facilitate study of drug breakdown both alone and when coupled to other Organ Chips that also contribute to drug metabolism (eg, Liver Chip) and clearance (eg, Kidney Chip) in a human Body-on-a-Chip configuration.36, 37”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pooling together different cells and/or organoids for bulk analysis can lead to inaccurate results3,70,100,204,207,208.”
From Organoids (2022) · cites this paper as [100]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Some devices integrated multiple chambers with different types of cells to measure PK and pharmacodynamics (PD) properties of drug compounds in vitro.35, 36, 37”
From Microfluidic Organ-on-a-Chip Models of Human Intestine (2018) · cites this paper as [37]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Physiological Parameters in Laboratory Animals and Humans
Davies, B., & Morris, T. (1993) · Pharmaceutical Research · doi:10.1023/a:1018943613122 · Cited by 2,926
Lundqvist, M., Stigler, J., Elia, G., Lynch, I., Cedervall, T., & Dawson, K. A. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0805135105 · Cited by 2,823
Kim, H. J., Huh, D., Hamilton, G., & Ingber, D. E. (2012) · Lab on a Chip · doi:10.1039/c2lc40074j · Cited by 1,734
Treating metastatic cancer with nanotechnology
Schroeder, A., Heller, D. A., Winslow, M. M., Dahlman, J. E., Pratt, G. W., Langer, R., Jacks, T., & Anderson, D. G. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3180 · Cited by 1,159
Tzima, E. (2001) · The EMBO Journal · doi:10.1093/emboj/20.17.4639 · Cited by 569
A toxicologist guide to the diagnostic interpretation of hepatic biochemical parameters
Ramaiah, S. K. (2007) · Food and Chemical Toxicology · doi:10.1016/j.fct.2007.06.007 · Cited by 494
Revisiting lab-on-a-chip technology for drug discovery
Neužil, P., Giselbrecht, S., Länge, K., Huang, T. J., & Manz, A. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3799 · Cited by 487
Nanoparticle-induced surface reconstruction of phospholipid membranes
Wang, B., Zhang, L., Bae, S. C., & Granick, S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807296105 · Cited by 469
Evaluation of nanoparticle immunotoxicity
Dobrovolskaia, M. A., Germolec, D. R., & Weaver, J. L. (2009) · Nature Nanotechnology · doi:10.1038/nnano.2009.175 · Cited by 368
Oral exposure to polystyrene nanoparticles affects iron absorption
Mahler, G. J., Esch, M. B., Tako, E., Southard, T. L., Archer, S. D., Glahn, R. P., & Shuler, M. L. (2012) · Nature Nanotechnology · doi:10.1038/nnano.2012.3 · Cited by 340
Cited by
TEER Measurement Techniques for In Vitro Barrier Model Systems
Srinivasan, B., Kolli, A. R., Esch, M. B., Abaci, H. E., Shuler, M. L., & Hickman, J. J. (2015) · SLAS Technology · doi:10.1177/2211068214561025 · Cited by 2,145
Advances in organ-on-a-chip engineering
Zhang, B., Korolj, A., Lai, B. F. L., & Radisic, M. (2018) · Nature Reviews Materials · doi:10.1038/s41578-018-0034-7 · Cited by 1,017
Zhao, Z., Chen, X., Dowbaj, A. M., Sljukic, A., Bratlie, K., Lin, L., Fong, E. L. S., Balachander, G. M., Chen, Z., Soragni, A., et al. (2022) · Nature Reviews Methods Primers · doi:10.1038/s43586-022-00174-y · Cited by 1,082
Modelling cancer in microfluidic human organs-on-chips
Sontheimer-Phelps, A., Hassell, B. A., & Ingber, D. E. (2019) · Nature Reviews Cancer · doi:10.1038/s41568-018-0104-6 · Cited by 906
Xuan, L., Ju, Z., Skonieczna, M., Zhou, P., & Huang, R. (2023) · MedComm · doi:10.1002/mco2.327 · Cited by 807
Microfluidic Organ-on-a-Chip Models of Human Intestine
Bein, A., Shin, W., Jalili-Firoozinezhad, S., Park, M. H., Sontheimer-Phelps, A., Tovaglieri, A., Chalkiadaki, A., Kim, H. J., & Ingber, D. E. (2018) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2017.12.010 · Cited by 625
Nanoparticles for oral delivery: Design, evaluation and state-of-the-art
Date, A. A., Hanes, J., & Ensign, L. M. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.06.016 · Cited by 539
“did not result in any measurable increase in cell permeability or cell death [129].”
BackgroundA microfluidic culture model of the human reproductive tract and 28-day menstrual cycle
Xiao, S., Coppeta, J. R., Rogers, H. B., Isenberg, B. C., Zhu, J., Olalekan, S. A., McKinnon, K. E., Dokic, D., Rashedi, A. S., Haisenleder, D. J., et al. (2017) · Nature Communications · doi:10.1038/ncomms14584 · Cited by 479
Multi-Organ toxicity demonstration in a functional human in vitro system composed of four organs
Oleaga, C., Bernabini, C., Smith, A. S. T., Srinivasan, B., Jackson, M., McLamb, W., Platt, V., Bridges, R., Cai, Y., Santhanam, N., et al. (2016) · Scientific Reports · doi:10.1038/srep20030 · Cited by 442
Self-citationOrgan-on-a-chip devices advance to market
Zhang, B., & Radisic, M. (2017) · Lab on a Chip · doi:10.1039/c6lc01554a · Cited by 437
Application of microfluidic chip technology in pharmaceutical analysis: A review
Cui, P., & Wang, S. (2019) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2018.12.001 · Cited by 390
Microfluidic Devices: A Tool for Nanoparticle Synthesis and Performance Evaluation
Gimondi, S., Ferreira, H., Reis, R. L., & Neves, N. M. (2023) · ACS Nano · doi:10.1021/acsnano.3c01117 · Cited by 376
Organ-on-a chip systems: microengineering to biomimic living systems
Zheng, F., Fu, F., Cheng, Y., Wang, C., Zhao, Y., & Gu, Z. (2016) · Small · doi:10.1002/smll.201503208 · Cited by 338
Rethinking organoid technology through bioengineering
Garreta, E., Kamm, R. D., Chuva de Sousa Lopes, S. M., Lancaster, M. A., Weiss, R., Trepat, X., Hyun, I., & Montserrat, N. (2021) · Nature Materials · doi:10.1038/s41563-020-00804-4 · Cited by 324
Magrì, D., Sánchez-Moreno, P., Caputo, G., Gatto, F., Veronesi, M., Bardi, G., Catelani, T., Guarnieri, D., Athanassiou, A., Pompa, P. P., et al. (2018) · ACS Nano · doi:10.1021/acsnano.8b01331 · Cited by 323
Organ-on-a-chip platforms: a convergence of advanced materials, cells, and microscale technologies
Ahadian, S., Civitarese, R., Bannerman, D., Mohammadi, M. H., Lu, R., Wang, E., Davenport‐Huyer, L., Lai, B., Zhang, B., Zhao, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700506 · Cited by 315
Sahlgren, C., Meinander, A., Zhang, H., Cheng, F., Preis, M., Xu, C., Salminen, T. A., Toivola, D., Abankwa, D., Rosling, A., et al. (2017) · Advanced Healthcare Materials · doi:10.1002/adhm.201700258 · Cited by 315
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
Marx, U. (2016) · ALTEX · doi:10.14573/altex.1603161 · Cited by 295
“ALTEX 33(3), 2016 285 A µCCA platform-based two-organ chip mimicking the gastrointestinal tract by a co-culture of CaCo-2 cells and the mucin producing cell line TH29-MTX, and the liver by a HepG2/C3A cell line culture has recently been described by Shuler’s team (Esch et al., 2014).”
Pumpless microfluidic platform for drug testing on human skin equivalents
Abaci, H. E., Gledhill, K., Guo, Z., Christiano, A. M., & Shuler, M. L. (2015) · Lab on a Chip · doi:10.1039/c4lc00999a · Cited by 262
Design and demonstration of a pumpless 14 compartment microphysiological system
Miller, P. G., & Shuler, M. L. (2016) · Biotechnology and Bioengineering · doi:10.1002/bit.25989 · Cited by 238
Liu, D., Zhang, H., Fontana, F., Hirvonen, J. T., & Santos, H. A. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.08.003 · Cited by 238
“Esch et al., 2014 [189] developed a system to simulate gastrointestinal and liver organs in one microfluidic chip, represented by co-culture of Caco-2/HT29-MTX cells and HepG2/C3A cells.”
BackgroundInfluentialGut-on-a-chip: Current progress and future opportunities
Ashammakhi, N., Nasiri, R., Barros, N. R. D., Tebon, P., Thakor, J., Goudie, M., Shamloo, A., Martin, M. G., & Khademhosseini, A. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120196 · Cited by 235
Domingues, C., Santos, A., Alvarez-Lorenzo, C., Concheiro, A., Jarak, I., Veiga, F., Barbosa, I., Dourado, M., & Figueiras, A. (2022) · ACS Nano · doi:10.1021/acsnano.2c00128 · Cited by 235
Deng, J., Wei, W., Chen, Z., Lin, B., Zhao, W., Luo, Y., & Zhang, X. (2019) · Micromachines · doi:10.3390/mi10100676 · Cited by 229
Esch, M. B., Ueno, H., Applegate, D. R., & Shuler, M. L. (2016) · Lab on a Chip · doi:10.1039/c6lc00461j · Cited by 222
Tsamandouras, N., Chen, W. L. K., Edington, C. D., Stokes, C. L., Griffith, L. G., & Cirit, M. (2017) · The AAPS Journal · doi:10.1208/s12248-017-0122-4 · Cited by 222
Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening
Ahn, J., Ko, J., Lee, S., Yu, J., Kim, Y., & Jeon, N. L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.001 · Cited by 213
Reverse engineering human pathophysiology with organs-on-chips
Ingber, D. E. (2016) · Cell · doi:10.1016/j.cell.2016.02.049 · Cited by 212
“Using a similar approach, another group has shown that ingested nanoparticles absorbed through a gastrointestinal chip have the potential to cause injury in a linked liver chip (Esch et al., 2014).”
BackgroundHiemstra, P. S., Grootaers, G., van der Does, A. M., Krul, C. A. M., & Kooter, I. M. (2018) · Toxicology in Vitro · doi:10.1016/j.tiv.2017.11.005 · Cited by 211
“An example of the usefulness of such an body-on-achip approach is described by Esch and co-workers, who demonstrated that “ingested” nanoparticles that were absorbed through a gastrointestinal chip could cause injury to cells in a linked liver chip (Esch et al., 2014).”
BackgroundMicrofluidic Gut-liver chip for reproducing the first pass metabolism
Choe, A., Ha, S. K., Choi, I., Choi, N., & Sung, J. H. (2017) · Biomedical Microdevices · doi:10.1007/s10544-016-0143-2 · Cited by 189
Prantil-Baun, R., Novak, R., Das, D., Somayaji, M. R., Przekwas, A., & Ingber, D. E. (2018) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104748 · Cited by 176
Organs-on-chips technologies – A guide from disease models to opportunities for drug development
Monteduro, A. G., Rizzato, S., Caragnano, G., Trapani, A., Giannelli, G., & Maruccio, G. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115271 · Cited by 175
Multi-cellular 3D human primary liver cell culture elevates metabolic activity under fluidic flow
Esch, M. B., Prot, J.-M., Wang, Y. I., Miller, P., Llamas-Vidales, J. R., Naughton, B. A., Applegate, D. R., & Shuler, M. L. (2015) · Lab on a Chip · doi:10.1039/c5lc00237k · Cited by 173
Self-citationIntegrated gut/liver microphysiological systems elucidates inflammatory inter‐tissue crosstalk
Chen, W. L. K., Edington, C., Suter, E., Yu, J., Velazquez, J. J., Velazquez, J. G., Shockley, M., Large, E. M., Venkataramanan, R., Hughes, D. J., et al. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26370 · Cited by 172
“This early work stimulated development of a variety of new multi-MPS platforms aimed at illuminating multi-organ interactions in pharmacological applications (Esch et al., 2014; Loskill et al., 2015; Maschmeyer et al., 2015b; Materne et al., 2015; Miller and Shuler, 2016; Oleaga et al., 2016; Rebelo et al., 2016; Sin…”
BackgroundMethodInfluentialMultiorgan Microphysiological Systems for Drug Development: Strategies, Advances, and Challenges
Wang, Y. I., Carmona, C., Hickman, J. J., & Shuler, M. L. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201701000 · Cited by 167
Kuorwel, K. K., Cran, M. J., Orbell, J. D., BUDDHADASA, S. C., & Bigger, S. W. (2015) · Comprehensive Reviews in Food Science and Food Safety · doi:10.1111/1541-4337.12139 · Cited by 168
Microfluidic Organ/Body-on-a-Chip Devices at the Convergence of Biology and Microengineering
Perestrelo, A., Águas, A., Rainer, A., & Forte, G. (2015) · Sensors · doi:10.3390/s151229848 · Cited by 149
In vitro and ex vivo systems at the forefront of infection modeling and drug discovery
Shi, D., Mi, G., Wang, M., & Webster, T. J. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.10.030 · Cited by 157
Comparison of conventional and advanced in vitro models in the toxicity testing of nanoparticles
Fröhlich, E. (2018) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2018.1479709 · Cited by 146
“This injury was observable at lower concentrations than in liver-only models, indicating that contact with Caco-2/H29-MTX cells made the particles more toxic [30].”
BackgroundOrgan‐on‐a‐Chip Technology for Reproducing Multiorgan Physiology
Lee, S. H., & Sung, J. H. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201700419 · Cited by 127
Recent progress in translational engineered in vitro models of the central nervous system
Nikolakopoulou, P., Rauti, R., Voulgaris, D., Shlomy, I., Maoz, B. M., & Herland, A. (2020) · Brain · doi:10.1093/brain/awaa268 · Cited by 143
“Such systems might ultimately provide the possibility of studying multi-organ physiological systems (Esch et al. , 2014; Maschmeyer et al. , 2015; Ingber, 2016).”
A pumpless multi‐organ‐on‐a‐chip (MOC) combined with a pharmacokinetic–pharmacodynamic (PK–PD) model
Lee, H., Kim, D. S., Ha, S. K., Choi, I., Lee, J. M., & Sung, J. H. (2017) · Biotechnology and Bioengineering · doi:10.1002/bit.26087 · Cited by 124
“, 2004), several research groups have reported MOC devices, containing the gut-liver (Esch et al., 2014; van Midwoud et al., 2010), liver-fat-blood vessel (Iori et al.”
BackgroundModeling Barrier Tissues In Vitro: Methods, Achievements, and Challenges
Sakolish, C. M., Esch, M. B., Hickman, J. J., Shuler, M. L., & Mahler, G. J. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.02.023 · Cited by 123
“This injurywas observable at lower concentrations thanwas observed in liver-onlymodels, indicating that compounding effects, or alteration of nanoparticle properties occurred in the GI module (Esch et al., 2014).”
BackgroundMcClements, D. J., DeLoid, G. M., Pyrgiotakis, G., Shatkin, J. A., Xiao, H., & Demokritou, P. (2016) · NanoImpact · doi:10.1016/j.impact.2016.10.002 · Cited by 131
“Most in vitro studies of iENM fate and toxicity have ignored these interactions, employing pristine ENMs suspended in culture media (Esch et al., 2014; Faust et al., 2014; Natarajan et al., 2015), often leading to erroneous conclusions (Gerloff et al.”
BackgroundFowler, S., Chen, W. L. K., Duignan, D. B., Gupta, A., Hariparsad, N., Kenny, J. R., Lai, W. G., Liras, J., Phillips, J. A., & Gan, J. (2020) · Lab on a Chip · doi:10.1039/c9lc00857h · Cited by 109
From 2D to 3D Cancer Cell Models—The Enigmas of Drug Delivery Research
Van Zundert, I., Fortuni, B., & Rocha, S. (2020) · Nanomaterials · doi:10.3390/nano10112236 · Cited by 107
“However, nanoparticles that crossed the GI could induce liver damage, as suggested by an increase of the aminotransferase (AST) release 24 h after nanoparticle administration [144].”
BackgroundLiver organ-on-chip models for toxicity studies and risk assessment
Messelmani, T., Morisseau, L., Sakai, Y., Legallais, C., Goff, A. L., Leclerc, É., & Jellali, R. (2022) · Lab on a Chip · doi:10.1039/d2lc00307d · Cited by 119
Organ-on-a-chip platforms for accelerating the evaluation of nanomedicine
Chen, X., Zhang, Y. S., Zhang, X., & Liu, C. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2020.09.022 · Cited by 107
“platforms, but more characterizations are still needed before they can be widely and accurately applied [91,128,129].”
BackgroundThe Gut–Organ-Axis Concept: Advances the Application of Gut-on-Chip Technology
Guo, Y., Chen, X., Gong, P., Li, G., Yao, W., & Yang, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24044089 · Cited by 114
“Bottom: Mean concentrations of aspartate aminotransferase (AST) and the percent area of on-chip liver chambers that was covered with viable HepG2/C3A cells after 24 h of exposure to 50 nm carboxylate polystyrene nanoparticles at varying concentrations [97] ©Copyright 2014, Royal Soc Chemistry.”
BackgroundMethodInfluentialThe emergence of 3D bioprinting in organ-on-chip systems
Fetah, K., Tebon, P., Goudie, M. J., Eichenbaum, J., Ren, L., Barros, N., Nasiri, R., Ahadian, S., Ashammakhi, N., Dokmeci, M. R., et al. (2019) · Progress in Biomedical Engineering · doi:10.1088/2516-1091/ab23df · Cited by 98
“One model of the gut-liver relationship focused on the ability of the intestinal barrier to reduce liver exposure to nanoparticles [196], while another has observed variable response to epirubicin, irinotecan, and cyclophosphamide in a lung-liver-gut microfluidic system [197].”
BackgroundMcAleer, C. W., Pointon, A., Long, C. J., Brighton, R. L., Wilkin, B. D., Bridges, L. R., Narasimhan Sriram, N., Fabre, K., McDougall, R., Muse, V. P., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-45656-4 · Cited by 96
He, Y., & Yin, R. (2023) · Journal of Applied Toxicology · doi:10.1002/jat.4510 · Cited by 110
“…direct research on these epithelial cells by MPs or NPs, according to animal studies (Liang et al., 2021) and tissue chip studies based on Caco-2 cells (Esch et al., 2014), epithelial cell apoptosis may be the main pathway for MPs or NPs to cross the epithelial cell layer to reach the target organ.”
BackgroundOrgans-on-a-chip: Current applications and consideration points for in vitro ADME-Tox studies
Ishida, S. (2018) · Drug Metabolism and Pharmacokinetics · doi:10.1016/j.dmpk.2018.01.003 · Cited by 106
Organ-on-a-chip technology for nanoparticle research
Kang, S., Park, S. E., & Huh, D. (2021) · Nano Convergence · doi:10.1186/s40580-021-00270-x · Cited by 108
Tissue Engineering and Regenerative Medicine 2015: A Year in Review
Wobma, H., & Vunjak-Novakovic, G. (2016) · Tissue Engineering Part B: Reviews · doi:10.1089/ten.teb.2015.0535 · Cited by 92
“Whether studying responses to a specific environmental factor (such as drug, hypoxia or inflammation) using a single or multi-tissue devices (68-71), the purpose of a platform should be to make the simplest system that has a desired functional readout.”
BackgroundMicrofluidic-based vascularized microphysiological systems
Lee, S., Ko, J., Park, D., Lee, S.-R., Chung, M., Lee, Y., & Jeon, N. L. (2018) · Lab on a Chip · doi:10.1039/c8lc00285a · Cited by 91
Engineered Liver Platforms for Different Phases of Drug Development
Ware, B. R., & Khetani, S. R. (2017) · Trends in Biotechnology · doi:10.1016/j.tibtech.2016.08.001 · Cited by 90
“Reproduced, with permission, from [65].”
BackgroundMicrofluidic nanomaterials: From synthesis to biomedical applications
Illath, K., Kar, S., Gupta, P., Shinde, A. S., Wankhar, S., Tseng, F., Lim, K., Nagai, M., & Santra, T. S. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.121247 · Cited by 93
Oral uptake of nanoparticles: human relevance and the role of in vitro systems
Fröhlich, E., & Roblegg, E. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1765-0 · Cited by 95
“Further work linked a fluidic intestinal cell model comprising Caco-2 cells and goblet cells with liver tissue, consisting of HepG2 and C3A (Esch et al. 2014).”
BackgroundSilicon dioxide nanoparticle exposure affects small intestine function in an in vitro model
Guo, Z., Martucci, N. J., Liu, Y., Yoo, E., Tako, E., & Mahler, G. J. (2018) · Nanotoxicology · doi:10.1080/17435390.2018.1463407 · Cited by 97
“A microfluidic GI tract model with periodic exposure to doses representing NP consumed in one meal would best recreate in vivo conditions (Mahler, Esch, Glahn and Shuler 2009; Esch et al. 2014).”
MethodMicrophysiological Systems: Design, Fabrication, and Applications
Wang, K., Man, K., Liu, J., Liu, Y., Chen, Q., Zhou, Y., & Yang, Y. S. (2020) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01667 · Cited by 90
Intestinal organ chips for disease modelling and personalized medicine
Özkan, A., LoGrande, N., Feitor, J. F., Goyal, G., & Ingber, D. E. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00968-3 · Cited by 109
“The same model was used to show that fluidic linking of liver and intestinal cells can exacerbate carboxylated polystyrene nanoparticle-induced liver injury as indicated by elevation of liver enzyme (aspartate aminotransferase) levels in the circulating medium 140 .”
Zhu, J., Ji, L., Chen, Y., Li, H., Huang, M., Dai, Z., Wang, J., Xiang, D., Fu, G., Lei, Z., et al. (2023) · Cell Death Discovery · doi:10.1038/s41420-023-01354-9 · Cited by 93
“At present, organ chips that encompass many organ types have been developed, including lung alveoli [42, 43] and bronchioles [44, 45], kidney [46, 47], liver [48], pancreas [49, 50], heart [51, 52], bone and bone marrow [53, 54] as well as the blood-brain barrier (BBB) [55, 56].”
Background3D gut-liver chip with a PK model for prediction of first-pass metabolism
Lee, D. W., Ha, S. K., Choi, I., & Sung, J. H. (2017) · Biomedical Microdevices · doi:10.1007/s10544-017-0242-8 · Cited by 85
Barriers-on-chips: Measurement of barrier function of tissues in organs-on-chips
Arık, Y. B., van der Helm, M. W., Odijk, M., Segerink, L. I., Passier, R. C., van den Berg, A., & van der Meer, A. D. (2018) · Biomicrofluidics · doi:10.1063/1.5023041 · Cited by 96
Advances in Using Nanotechnology Structuring Approaches for Improving Food Packaging
Mei, L., & Wang, Q. (2020) · Annual Review of Food Science and Technology · doi:10.1146/annurev-food-032519-051804 · Cited by 82
Organ-Tumor-on-a-Chip for Chemosensitivity Assay: A Critical Review
Kashaninejad, N., Nikmaneshi, M., Moghadas, H., Kiyoumarsi Oskouei, A., Rismanian, M., Barisam, M., Saidi, M., & Firoozabadi, B. (2016) · Micromachines · doi:10.3390/mi7080130 · Cited by 79
“According to metabolize cascade between liver and intestinal system [113,114], their co-culturing called liver–gastrointestinal system is strictly suggested particularly in studies of oral-drug development [115].”
BackgroundIntegration Concepts for Multi-Organ Chips: How to Maintain Flexibility?!
Rogal, J., Probst, C., & Loskill, P. (2017) · Future Science OA · doi:10.4155/fsoa-2016-0092 · Cited by 86
Organ-on-a-chip platforms for evaluation of environmental nanoparticle toxicity
Lu, R. X. Z., & Radisic, M. (2021) · Bioactive Materials · doi:10.1016/j.bioactmat.2021.01.021 · Cited by 94
Microfluidic lumen-based systems for advancing tubular organ modeling
Virumbrales-Muñoz, M., Ayuso, J. M., Gong, M. M., Humayun, M., Livingston, M. K., Lugo-Cintrón, K. M., McMinn, P., Álvarez-García, Y. R., & Beebe, D. J. (2020) · Chemical Society Reviews · doi:10.1039/d0cs00705f · Cited by 76
Sustainability and environmental ethics for the application of engineered nanoparticles
Besha, A. T., Liu, Y., Bekele, D. N., Dong, Z., Naidu, R., & Gebremariam, G. N. (2019) · Environmental Science & Policy · doi:10.1016/j.envsci.2019.10.013 · Cited by 83
de Haan, P., Ianovska, M. A., Mathwig, K., van Lieshout, G. A. A., Triantis, V., Bouwmeester, H., & Verpoorte, E. M. J. (2019) · Lab on a Chip · doi:10.1039/c8lc01080c · Cited by 77
Deng, J., Zhang, X., Chen, Z., Luo, Y., Lu, Y., Liu, T., Wu, Z., Jin, Y., Zhao, W., & Lin, B. (2019) · Biomicrofluidics · doi:10.1063/1.5070088 · Cited by 70
Microfluidic Organ-on-a-Chip Devices for Liver Disease Modeling In Vitro
Kanabekova, P., Kadyrova, A., & Kulsharova, G. (2022) · Micromachines · doi:10.3390/mi13030428 · Cited by 70
Wu, Y., Geng, X., Wang, J., Miao, Y., Lu, Y., & Li, B. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9316-2 · Cited by 72
Kumar, V., & Varghese, S. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801198 · Cited by 68
The impact of nanomaterial characteristics on inhalation toxicity
Bierkandt, F. S., Leibrock, L., Wagener, S., Laux, P., & Luch, A. (2018) · Toxicology Research · doi:10.1039/c7tx00242d · Cited by 73
Organoid technologies for the study of intestinal microbiota–host interactions
Bozzetti, V., & Senger, S. (2022) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2022.02.001 · Cited by 75
Santbergen, M. J. C., van der Zande, M., Gerssen, A., Bouwmeester, H., & Nielen, M. W. F. (2019) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-019-02336-6 · Cited by 72
Ashammakhi, N. A., Darabi, M. A., Çelebi‐Saltik, B., Tutar, R., Hartel, M. C., Lee, J., Hussein, S. M., Goudie, M. J., Cornelius, M. B., Dokmeci, M. R., et al. (2019) · Small Methods · doi:10.1002/smtd.201900589 · Cited by 74
A holistic analysis of the intrinsic and delivery-mediated toxicity of siRNA therapeutics
Ranjbar, S., Zhong, X., Manautou, J. E., & Lü, X. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.115052 · Cited by 72
Advances in Engineered Liver Models for Investigating Drug-Induced Liver Injury
Lin, C., & Khetani, S. R. (2016) · BioMed Research International · doi:10.1155/2016/1829148 · Cited by 66
Impact of nanotechnology on the oral delivery of phyto-bioactive compounds
Nsairat, H., Lafi, Z., Al-Sulaibi, M., Gharaibeh, L. F., & Alshaer, W. (2023) · Food Chemistry · doi:10.1016/j.foodchem.2023.136438 · Cited by 73
Long‐Term Electrical and Mechanical Function Monitoring of a Human‐on‐a‐Chip System
Oleaga, C., Lavado, A., Riu, A., Rothemund, S., Carmona‐Moran, C. A., Persaud, K., Yurko, A., Lear, J., Narasimhan, N. S., Long, C. J., et al. (2019) · Advanced Functional Materials · doi:10.1002/adfm.201805792 · Cited by 63
De Gregorio, V., Telesco, M., Corrado, B., Rosiello, V., Urciuolo, F., Netti, P. A., & Imparato, G. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00163 · Cited by 62
“However, even if these systems (Esch et al., 2014) provide important insights into the molecular mechanism of GI tract metabolism, they include over-simplified cell mono or co-culture models, thus failing in the replication of the 3D physiological ECM microenvironment with its dynamic complexity.”
BackgroundPrasad, M., Kumar, R., Buragohain, L., Kumari, A., & Ghosh, M. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.696668 · Cited by 63
Tutty, M. A., Movia, D., & Prina‐Mello, A. (2022) · Drug Delivery and Translational Research · doi:10.1007/s13346-022-01147-0 · Cited by 75
“A recent example of MPS where a GI/liver MPS incorporating co-cultures of Caco-2/ HT29-MTX and HepG2/C3A liver cells has been successfully applied for investigating first pass metabolism of high doses of polystyrene nanoparticles intended for daily human consumption [90].”
BackgroundMethodSelf-contained, low-cost Body-on-a-Chip systems for drug development
Wang, Y. I., Oleaga, C., Long, C. J., Esch, M. B., McAleer, C. W., Miller, P. G., Hickman, J. J., & Shuler, M. L. (2017) · Experimental Biology and Medicine · doi:10.1177/1535370217694101 · Cited by 59
“Two-organ systems of GI tract and liver have been developed previously on a platform that was operated with pumps to estimate the bioavailability of acetaminophen,(48) and to evaluate the effects of 50 nm polystyrene nanoparticles on the GI tract and on liver tissue.(93) The latest version of the GI tract–liver system…”
BackgroundSelf-citationCastro, F., Pereira, C. L., Macedo, M. H., Almeida, A., Silveira, M. J., Dias, S., Cardoso, A. P., Oliveira, M. J., & Sarmento, B. F. C. C. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.06.001 · Cited by 66
Safety and fate of nanomaterials in food: The role of in vitro tests
Xavier, M., Parente, I. A., Rodrigues, P. M., Cerqueira, M. Â., Pastrana, L. M., & Gonçalves, C. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.01.050 · Cited by 61
Hepatotoxicity induced by nanomaterials: mechanisms and in vitro models
Vilas‐Boas, V., & Vinken, M. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02940-x · Cited by 63
Liver-on-a-chip devices: the pros and cons of complexity
Dalsbecker, P., Adiels, C. B., & Goksör, M. (2022) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00346.2021 · Cited by 64
Engineered Biomimetic Membranes for Organ-on-a-Chip
Rahimnejad, M., Rasouli, F., Jahangiri, S., Ahmadi, S., Rabiee, N., Farani, M. R., Akhavan, O., Asadnia, M., Fatahi, Y., Hong, S., et al. (2022) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.2c00531 · Cited by 59
Assessment of metabolism-dependent drug efficacy and toxicity on a multilayer organs-on-a-chip
Li, Z., Guo, Y., Yu, Y., Xu, C., Xu, H., & Qin, J. (2016) · Integrative Biology · doi:10.1039/c6ib00162a · Cited by 54
In vitro and ex vivo models for evaluating vaginal drug delivery systems
Shapiro, R. L., DeLong, K., Zulfiqar, F., Carter, D. M., Better, M., & Ensign, L. M. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114543 · Cited by 60
Organ-On-A-Chip: An Emerging Research Platform
Nithin, R., Aggarwal, A., Sravani, A. B., Mallya, P., & Lewis, S. A. (2023) · Organogenesis · doi:10.1080/15476278.2023.2278236 · Cited by 69
Multi-organ-on-a-chip for pharmacokinetics and toxicokinetic study of drugs
Sung, J. H. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1908996 · Cited by 58
Acetaminophen absorption and metabolism in an intestine/liver microphysiological system
Marin, T. M., de Carvalho Indolfo, N., Rocco, S. A., Basei, F. L., de Carvalho, M., de Almeida Gonçalves, K., & Pagani, E. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2018.11.010 · Cited by 50
Heddagaard, F. E., & Möller, P. (2019) · Food and Chemical Toxicology · doi:10.1016/j.fct.2019.111106 · Cited by 59
Metadata
- Authors
- Esch, M. B., Mahler, G. J., Stokol, T., & Shuler, M. L.
- Affiliations
- Cornell University (US)
- Binghamton University (US)
- Corresponding author
- Shuler, Michael L.
- Venue
- Lab Chip
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 14
- Issue
- 16
- Pages
- 3081-3092
- ISSN
- 1473-0189 (ISSN-L)
- 1473-0197
- PMC
- PMC4144667
- OpenAlex
- W2030338281
- Cited by
- 281
- References
- 37
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 16 · 2023: 30 · 2022: 20 · 2021: 27 · 2020: 23 · 2019: 28 · 2018: 30 · 2017: 25 · 2016: 31 · 2015: 12 · 2014: 4
- FWCI
- 10.88
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Lab on a Chip (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Science Foundation
- National Institutes of Health (UH2TR000516)
- National Center for Advancing Translational Sciences
- U.S. Army Corps of Engineers
- Topics
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Immunology and Microbiology › Immunology › Immunotoxicology and immune responses
- Keywords
- body-on-a-chip, organ-on-a-chip, gastrointestinal tract, liver injury, Caco-2/HT29-MTX co-culture, intestinal epithelial barrier, nanoparticle transport, nanoparticle aggregation, nanoparticle toxicity
- MeSH terms
- Analysis of Variance, Cell Line, Cell Survival, Humans, Intestinal Mucosa, Liver, Models, Biological, Toxicity Tests, Cell Culture Techniques, Gastrointestinal Tract, Microfluidic Analytical Techniques, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.